Complications, diagnosis and therapy of heparin-induced thrombocytopenia (HIT) type II;Die heparininduzierte thrombozytopenie vom typ II (HIT-typ II): Komplikationen, diagnostik und therapie

Aktuelle Neurologie

Volumn 26, Issue 1, 1999, Pages 25-30

  Rosel T ^a   Druschky, K F ^b   Greinacher, A ^b  

^a Neurologische Klinik   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; HEPARIN;

ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; HEART INFARCTION; HEPARINIZATION; HUMAN; INTRACRANIAL PRESSURE; LABORATORY DIAGNOSIS; MALE; MORTALITY; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0345434970     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017604     Document Type: Article

References (30)

1. Becker, P. S., V. T. Miller: Heparin-induced thrombocytopenia. Stroke 20 (1989) 1449-1459
2. Busse, O.: Anticoagulants in ischaemic stroke. Curr. Opin. Therapy Pat. 3 (1991) 375-387
3. Calhoun, B. C., J. W. Hesser: Heparin-associated antibody with pregnancy: Discussion of two cases. Am. J. Obstet. Gynecol. 156 (1987) 964-966
4. Chong, B. H.: Heparin-induced thrombocytopenia. Aust. NZ. J. Med. 22 (1992) 145-152
5. Chong, B. H., M. C. Berndt: Heparin-induced thrombocytopenia. Blut 58 (1989) 53-57
6. Einhäupl, K. M., S. Mehraein, R. L. Haberl et al.: Heparin treatment in sinus venous thrombosis. Lancet 338 (1991) 597-600
7. Greinacher, A.: Heparin-induzierte Thrombozytopenien. Internist 37 (1996) 1172-1178
8. Greinacher, A., H. Völpel, B. Pötzsch: Recombinant hirudin in the treatment of patients with heparin-induced thrombocytopenia (HIT) (abstract). Blood 88, Suppl. (1996) 281 A
9. Greinacher, A., J. Amiral, V. Dummel et al: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin induced platelet activation test and platelet factor 4/heparin-enzyme linked immunosorbent assay. Transfusion 34 (1994) 381-385
10. Greinacher, A., P. Eichler: Die Heparin-assoziierte Thrombozytopenie - Immunologische Aspekte. Hämost. 15 (1995) 117-121
11. Greinacher, A., I. Michels, V. Kiefel et al.: A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thrombos. Haemostas. 66 (1991) 734-736
12. International Stroke Trial Collaborative Group: International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 (1997) 1569-1581
13. Kapsch, D. N., E. H. Adelstein, G. R. Rhodes et al.: Heparin-induced thrombocytopenia, thrombosis and hemorrhage. Surgery 86 (1979) 148-155
14. King, D. J., J. G. Kelton: Heparin-associated thrombocytopenia. Ann. Intern. Med. 100 (1984) 535-540
15. Kyritsis, A. P., E. C. Williams, H. S. Schutta: Cerebral venous thrombosis due to heparin-induced thrombocytopenia. Stroke 21 (1990) 1503-1505
16. Magnani, H. N.: Orgaran (danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia. Platelets 8 (1997) 74-81
17. Nelson, J. C., R. G. Lerner, R. Goldstein et al.: Heparin-induced thrombocytopenia. Arch. Intern. Med. 138 (1978) 548-552
18. Peters, F. P. J., P. A. F. M. Doevendans, F. L. G. Erdkamp et al.: Low molecular weight heparin-induced thrombocytopenia and thrombosis. Eur. J. Haematol. 56 (1996) 329-330
19. Rhodes, G. R., R. H. Dixon, D. Silver: Heparin-induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg. Gynecol. Obstet. 136 (1973) 409-416
20. Sandercock, P. A. G., A. G. M. van den Belt, R. I. Lindley et al.: Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J. Neurol. Neurosurg. Psychiatry 56 (1993) 17-25
21. Scharf, R. E., A. Greinacher, H. Riess et al.: Empfehlung zu der Bekanntmachung der Arzneimittelkommission der deutschen Ärzteschaft "unerwünschte Arzneimittelwirkungen duch fraktionierte und unfraktionierte Heparine" (Dt. Ärzteblatt 41/1992) und zum Stufenplan des Bundesgesundheitsamtes "Heparinhaltige Arzneimittel zur parenteralen Anwendung" (Dt. Ärztebl. 47/ 1992). Dt. Ärztebl. 91 (1994) B-1293
22. Schmitt, B. P., B. Adelman: Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am. J. Med. Sci. 305 (1993) 208-215
23. Stevenson, M. M.: Thrombocytopenia during heparin therapy (letter). N. Engl. J. Med. 295 (1976) 1200-1201
24. Stichtmann, C., R. Schreiner, K. A. Flügel: Sinusvenenthrombose als Folge einer heparinassoziierten Thrombozytopenie (HAT Typ II). Akt. Neurol. 22 (1995) 236-239
25. Van der Weyden, M. B., H. Hunt, K. Mc Grath et al.: Delayed-onset heparin induced thrombocytopenia. A potentially malignant syndrome. Med. J. Aust. 2 (1983) 132-135
26. Warkentin, T. E.: Danaparoid (Orgaran) for the treatment of heparin-induced thrombocytopenia (HIT) and thrombosis: Effects on in vivo thrombin and cross-linked fibrin generation, and evaluation of the clinical significance of in vitro cross-reactivity (XR) of danaparoid for HIT-IgG (abstract). Blood 88, Suppl. (1996) 626 A
27. Warkentin, T. E., B. H. Chong, A. Greinacher: Heparin-induced thrombocytopenia: towards consensus. Thromb. Haemost. 79 (1998) 1-7
28. Warkentin, T. E., J. G. Kelton: Heparin-induced thrombocytopenia. In: Coller, B. S. (ed.): Progress in Hemostasis and Thrombosis. Vol. 10. WB Saunders Comp., Philadelphia (1991) 1-34
29. Warkentin, T. E., J. G. Kelton: A 14-year study of heparin-induced thrombytopenia. Am. J. Med. 101 (1996) 502-507
30. Warkentin, T. E., M. N. Levine, J. Hirsh et al.: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractioned heparin. N. Engl. J. Med. 332 (1995) 1330-1335